Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (002864) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.016x

Based on the latest financial reports, Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (002864) has a cash flow conversion efficiency ratio of 0.016x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥26.54 Million ≈ $3.88 Million USD) by net assets (CN¥1.69 Billion ≈ $246.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 002864 company net worth for the company's overall valuation and market capitalisation.

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A ranked by their cash flow conversion efficiency. Explore Shaanxi Panlong Pharmaceutical Group Lim cash earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
3I Group PLC LSE:III	0.001x
Shenzhen Ruihe Construction Decoration Co Ltd SHE:002620	0.302x
Allot Communications Ltd TA:ALLT	0.073x
Hunan Baili Engineering Sci SHG:603959	0.820x
Materialise NV NASDAQ:MTLS	0.027x
Zhejiang Yangfan New Materials Co Ltd SHE:300637	0.053x
Daeduck Co. Ltd. KO:008060	0.008x
Guangdong Tianhe Agricultural Means SHE:002999	-0.233x

Annual Cash Flow Conversion Efficiency for Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (2013–2025)

The table below shows the annual cash flow conversion efficiency of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A from 2013 to 2025. View today's stock price for Shaanxi Panlong Pharmaceutical Group Lim for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.69 Billion ≈ $247.16 Million	CN¥63.01 Million ≈ $9.22 Million	0.037x	-61.00%
2024-12-31	CN¥1.64 Billion ≈ $239.57 Million	CN¥156.59 Million ≈ $22.91 Million	0.096x	+42.60%
2023-12-31	CN¥1.55 Billion ≈ $227.00 Million	CN¥104.05 Million ≈ $15.23 Million	0.067x	-49.30%
2022-12-31	CN¥947.60 Million ≈ $138.66 Million	CN¥125.36 Million ≈ $18.34 Million	0.132x	-7.97%
2021-12-31	CN¥807.21 Million ≈ $118.12 Million	CN¥116.04 Million ≈ $16.98 Million	0.144x	+14.65%
2020-12-31	CN¥735.66 Million ≈ $107.65 Million	CN¥92.24 Million ≈ $13.50 Million	0.125x	+24.61%
2019-12-31	CN¥674.71 Million ≈ $98.73 Million	CN¥67.89 Million ≈ $9.93 Million	0.101x	+31.36%
2018-12-31	CN¥611.60 Million ≈ $89.50 Million	CN¥46.85 Million ≈ $6.86 Million	0.077x	+49.58%
2017-12-31	CN¥555.58 Million ≈ $81.30 Million	CN¥28.45 Million ≈ $4.16 Million	0.051x	-72.92%
2016-12-31	CN¥327.82 Million ≈ $47.97 Million	CN¥61.99 Million ≈ $9.07 Million	0.189x	+34.49%
2015-12-31	CN¥288.89 Million ≈ $42.27 Million	CN¥40.62 Million ≈ $5.94 Million	0.141x	-28.71%
2014-12-31	CN¥246.19 Million ≈ $36.03 Million	CN¥48.56 Million ≈ $7.11 Million	0.197x	+63.50%
2013-12-31	CN¥210.84 Million ≈ $30.85 Million	CN¥25.43 Million ≈ $3.72 Million	0.121x	--

About Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A

SHE:002864 China Drug Manufacturers - Specialty & Generic

Market Cap

$319.75 Million

CN¥2.19 Billion CNY

Market Cap Rank

#14616 Global

#4378 in China

Share Price

CN¥20.56

Change (1 day)

+0.49%

52-Week Range

CN¥20.18 - CN¥39.20

All Time High

CN¥74.44